T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
2126
DELISTED
Axonics, Inc. Common Stock
AXNX
| $616K | ﹤0.01% |
10,866
+326
| +3% | +$17.9K |
|
|
RDFN
2127
DELISTED
Redfin
RDFN
| $614K | ﹤0.01% |
74,503
+13,291
| +22% | +$152K |
|
2128
LivePerson
LPSN
$35.9M
| $612K | ﹤0.01% |
2,887
+300
| +12% | +$84.4K |
|
2129
Urban Outfitters
URBN
$6.53B
| $612K | ﹤0.01% |
32,812
+128
| +0.4% | +$2.9K |
|
2130
Brookfield Renewable
BEP
$10.6B
| $611K | ﹤0.01% |
17,563
+107
| +0.6% | +$3.85K |
|
2131
Scansource
SCSC
$1.06B
| $610K | ﹤0.01% |
19,574
+202
| +1% | +$7.08K |
|
2132
Myriad Genetics
MYGN
$303M
| $606K | ﹤0.01% |
33,334
+509
| +2% | +$10.6K |
|
|
SGMO
2133
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $606K | ﹤0.01% |
146,310
+5,700
| +4% | +$24.6K |
|
|
HEES
2134
DELISTED
H&E Equipment Services
HEES
| $605K | ﹤0.01% |
20,890
+167
| +0.8% | +$5.87K |
|
2135
Xerox
XRX
$412M
| $602K | ﹤0.01% |
40,510
+3,346
| +9% | +$59.3K |
|
2136
B&G Foods
BGS
$299M
| $601K | ﹤0.01% |
25,290
+254
| +1% | +$6.31K |
|
2137
Unitil
UTL
$992M
| $600K | ﹤0.01% |
10,223
-6,022
| -37% | -$325K |
|
2138
Innoviva
INVA
$1.5B
| $598K | ﹤0.01% |
40,538
+2,200
| +6% | +$36K |
|
2139
Kyndryl
KD
$3.04B
| $598K | ﹤0.01% |
61,126
-594,221
| -91% | -$6.92M |
|
|
BRG
2140
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $598K | ﹤0.01% |
22,736
-3,364
| -13% | -$88.9K |
|
|
PRPC
2141
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $597K | ﹤0.01% |
60,625
| – | – |
|
|
VISN
2142
Vistance Networks Inc
VISN
$2.62B
| $596K | ﹤0.01% |
97,395
+23,936
| +33% | +$167K |
|
2143
Verra Mobility
VRRM
$731M
| $595K | ﹤0.01% |
37,844
+365
| +1% | +$5.54K |
|
|
BBBY
2144
Bed Bath & Beyond
BBBY
$423M
| $593K | ﹤0.01% |
26,089
+335
| +1% | +$10.1K |
|
2145
Agilysys
AGYS
$3.25B
| $592K | ﹤0.01% |
12,518
-37
| -0.3% | -$1.44K |
|
|
EBIX
2146
DELISTED
Ebix Inc
EBIX
| $587K | ﹤0.01% |
34,727
+21,660
| +166% | +$606K |
|
2147
Sally Beauty Holdings
SBH
$1.55B
| $586K | ﹤0.01% |
49,121
-9,889
| -17% | -$144K |
|
2148
Empire State Realty Trust
ESRT
$836M
| $585K | ﹤0.01% |
83,230
+324
| +0.4% | +$2.63K |
|
2149
Artivion
AORT
$1.39B
| $584K | ﹤0.01% |
30,948
+306
| +1% | +$5.9K |
|
|
TEN
2150
PUT
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $583K | ﹤0.01% |
+34,000
| New | +$574K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.